Exponent VP sells 4,000 shares in open market

Exponent Inc.'s VP Global Offices & Innovation, John Pye, reported selling a total of 4,000 shares of common stock in open-market transactions on February 10, 2026.

Rhea-AI Filing Summary

Exponent Inc.'s VP Global Offices & Innovation, John Pye, reported selling a total of 4,000 shares of common stock in open-market transactions on February 10, 2026. The sales occurred in two trades: 341 shares at $75.935 and 3,659 shares at $75.9781 per share.

Following these sales, Pye directly owns 25,204 shares of Exponent common stock. All reported holdings are listed as directly owned, with no indirect ownership disclosed in this filing.

Insider Trade Summary

Net Seller: 4,000 shares

Net Sell 2 txns

Insider Pye John

Role VP Global Offices & Innovation

Sold 4,000 shs ($304K)

Type	Security	Shares	Price	Value
Sale	Common Stock	341	$75.935	$26K
Sale	Common Stock	3,659	$75.9781	$278K

Holdings After Transaction: Common Stock — 25,204 shares (Direct)

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did EXPO’s John Pye report on this Form 4?

John Pye, VP Global Offices & Innovation at Exponent Inc. (EXPO), reported selling common stock in open-market transactions on February 10, 2026. The filing details two separate sales and his updated direct ownership after these trades.

How many Exponent (EXPO) shares did John Pye sell and at what prices?

John Pye sold a total of 4,000 Exponent common shares. He sold 341 shares at $75.935 per share and 3,659 shares at $75.9781 per share, both categorized as open-market sales under transaction code “S”.

What is John Pye’s remaining Exponent (EXPO) share ownership after the sale?

After the reported transactions, John Pye directly owns 25,204 shares of Exponent common stock. The Form 4 shows this figure as his beneficially owned amount following the sales, with the ownership form listed as direct rather than indirect.

What role does John Pye hold at Exponent Inc. (EXPO)?

John Pye is identified as an officer of Exponent Inc., serving as VP Global Offices & Innovation. The filing indicates he is not a director and not a 10% owner, framing this as an executive-level insider transaction.

Were John Pye’s EXPO share sales direct or through an intermediary entity?

The reported Exponent share sales are classified as direct ownership (D) transactions. The Form 4 lists no nature of indirect beneficial ownership and provides no footnotes indicating that the trades were executed through a trust, LLC, or other related entity.

What transaction code is used for John Pye’s Exponent (EXPO) stock sales?

Both transactions use code “S”, which the filing describes as a sale in open market or private transaction. This indicates the trades were dispositions of stock, not option exercises or grants, and reduced his directly held share count.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/12/2026 - 01:28 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Pye John

(Last) (First) (Middle)

149 COMMONWEALTH DRIVE

(Street)

MENLO PARK CA 94025

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
EXPONENT INC [ EXPO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	VP Global Offices & Innovation

3. Date of Earliest Transaction (Month/Day/Year)
02/10/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/10/2026		S		341	D	$75.935	28,863	D
Common Stock	02/10/2026		S		3,659	D	$75.9781	25,204	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	By: Wendy Whitehouse For: John Pye	02/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.